Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages

Mitchel Tate(Queen's University Belfast), David Grieve(Queen's University Belfast)

Basic Research in Cardiology

November 23, 2015

10.1007/s00395-015-0518-1

Cited by 96

Related Papers

Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix

|Basic Research in Cardiology|2015|67

Metabolically-inactive glucagon-like peptide-1(9–36)amide confers selective protective actions against post-myocardial infarction remodelling

|Cardiovascular Diabetology|2016|35

PLAC8-Mediated Activation of NOX4 Signalling Restores Angiogenic Function of Endothelial Colony-Forming Cells in Experimental Hypoxia

|Cells|2023|5